BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Heebøll S, Thomsen KL, Pedersen SB, Vilstrup H, George J, Grønbæk H. Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease. World J Hepatol 2014; 6(4): 188-198 [PMID: 24799987 DOI: 10.4254/wjh.v6.i4.188]
URL: https://www.wjgnet.com/1948-5182/full/v6/i4/188.htm
Number Citing Articles
1
Chih-Chun Chang, Chieh-Yu Chang, Pei-Chun Lin, Jiung-Pang Huang, Kuan-Hsing Chen, Tzung-Hai Yen, Li-Man Hung. Administration of low-dose resveratrol attenuated hepatic inflammation and lipid accumulation in high cholesterol-fructose diet-induced rat model of nonalcoholic fatty liver diseaseChinese Journal of Physiology 2020; 63(4): 149 doi: 10.4103/CJP.CJP_43_20
2
Weigang Yuan, Mi Zhang, Chunxu Wang, Bin Li, Lei Li, Feng Ye, Chuanrui Xu. Resveratrol Attenuates High-Fat Diet–Induced Hepatic Lipotoxicity by Upregulating Bmi-1 ExpressionJournal of Pharmacology and Experimental Therapeutics 2022; 381(2): 96 doi: 10.1124/jpet.121.001018
3
Julia Christenson, Serena J. Whitby, Duane Mellor, Jackson Thomas, Andrew McKune, Paul D. Roach, Nenad Naumovski. The Effects of Resveratrol Supplementation in Overweight and Obese Humans: A Systematic Review of Randomized TrialsMetabolic Syndrome and Related Disorders 2016; 14(7): 323 doi: 10.1089/met.2016.0035
4
Jung-Hwan Kang, Se-Young Choung. Protective effects of resveratrol and its analogs on age-related macular degeneration in vitroArchives of Pharmacal Research 2016; 39(12): 1703 doi: 10.1007/s12272-016-0839-0
5
Cong Liu, Jia-Zhi Liao, Pei-Yuan Li. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver diseaseWorld Journal of Gastroenterology 2017; 23(11): 1964-1973 doi: 10.3748/wjg.v23.i11.1964
6
Fu-Chao Liu, Yung-Fong Tsai, Hsin-I Tsai, Huang-Ping Yu. Anti-Inflammatory and Organ-Protective Effects of Resveratrol in Trauma-Hemorrhagic InjuryMediators of Inflammation 2015; 2015: 1 doi: 10.1155/2015/643763
7
Haoyue Deng, Man-tian Mi. Resveratrol Attenuates Aβ25–35 Caused Neurotoxicity by Inducing Autophagy Through the TyrRS-PARP1-SIRT1 Signaling PathwayNeurochemical Research 2016; 41(9): 2367 doi: 10.1007/s11064-016-1950-9
8
Jenifer Trepiana, Iñaki Milton-Laskibar, Saioa Gómez-Zorita, Itziar Eseberri, Marcela González, Alfredo Fernández-Quintela, María Portillo. Involvement of 5′-Activated Protein Kinase (AMPK) in the Effects of Resveratrol on Liver SteatosisInternational Journal of Molecular Sciences 2018; 19(11): 3473 doi: 10.3390/ijms19113473
9
Marlies de Ligt, Silvie Timmers, Patrick Schrauwen. Resveratrol and obesity: Can resveratrol relieve metabolic disturbances?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(6): 1137 doi: 10.1016/j.bbadis.2014.11.012
10
Ali Bayoumi, Henning Grønbæk, Jacob George, Mohammed Eslam. The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver DiseaseTrends in Genetics 2020; 36(6): 429 doi: 10.1016/j.tig.2020.03.003
11
Sharon M. Gwaltney-Brant. Nutraceuticals2021; : 117 doi: 10.1016/B978-0-12-821038-3.00008-2
12
Eva Dolezelova, Alena Prasnicka, Jolana Cermanova, Alejandro Carazo, Lucie Hyrsova, Milos Hroch, Jaroslav Mokry, Michaela Adamcova, Alena Mrkvicova, Petr Pavek, Stanislav Micuda. Resveratrol modifies biliary secretion of cholephilic compounds in sham-operated and cholestatic ratsWorld Journal of Gastroenterology 2017; 23(43): 7678-7692 doi: 10.3748/wjg.v23.i43.7678
13
Chan Yoon Park, Sung Nim Han. The Molecular Nutrition of Fats2019; : 103 doi: 10.1016/B978-0-12-811297-7.00008-1
14
Antje Bruckbauer, Jheelam Banerjee, Lizhi Fu, Fenfen Li, Qiang Cao, Xin Cui, Rui Wu, Hang Shi, Bingzhong Xue, Michael B. Zemel. A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in MiceInternational Journal of Hepatology 2016; 2016: 1 doi: 10.1155/2016/9185987
15
HUI ZHANG, QINGFENG SUN, TINGYAN XU, LIANG HONG, RONGQUAN FU, JINGUO WU, JIGUANG DING. Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathwaysMolecular Medicine Reports 2016; 13(1): 224 doi: 10.3892/mmr.2015.4497
16
Akhand Pratap Singh, Rachna Singh, Sumit Singh Verma, Vipin Rai, Catherine H. Kaschula, Pralay Maiti, Subash Chandra Gupta. Health benefits of resveratrol: Evidence from clinical studiesMedicinal Research Reviews 2019; 39(5): 1851 doi: 10.1002/med.21565
17
Yong Zhang, Ming-liang Chen, Yong Zhou, Long Yi, Yan-xiang Gao, Li Ran, Shi-hui Chen, Ting Zhang, Xi Zhou, Dan Zou, Bin Wu, Ying Wu, Hui Chang, Jun-dong Zhu, Qian-yong Zhang, Man-tian Mi. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathwayMolecular Nutrition & Food Research 2015; 59(8): 1443 doi: 10.1002/mnfr.201500016
18
Manuela Pennisi, Gaetano Bertino, Caterina Gagliano, Michele Malaguarnera, Rita Bella, Antonio Borzì, Roberto Madeddu, Filippo Drago, Giulia Malaguarnera. Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep DisturbanceNutrients 2017; 9(8): 897 doi: 10.3390/nu9080897
19
Tomasz Charytoniuk, Ewa Harasim-Symbor, Agnieszka Polak, Krzysztof Drygalski, Klaudia Berk, Adrian Chabowski, Karolina Konstantynowicz-Nowicka. Influence of Resveratrol on Sphingolipid Metabolism in Hepatocellular Carcinoma Cells in Lipid Overload StateAnti-Cancer Agents in Medicinal Chemistry 2019; 19(1): 121 doi: 10.2174/1871520619666181224161255
20
Laura K. Cole, Edgard M. Mejia, Genevieve C. Sparagna, Marilyne Vandel, Bo Xiang, Xianlin Han, Nikolaos Dedousis, Brett A. Kaufman, Vernon W. Dolinsky, Grant M. Hatch. Cardiolipin deficiency elevates susceptibility to a lipotoxic hypertrophic cardiomyopathyJournal of Molecular and Cellular Cardiology 2020; 144: 24 doi: 10.1016/j.yjmcc.2020.05.001
21
Sara Heebøll, Rime Bahij El-Houri, Ylva Erika Kristina Hellberg, David Haldrup, Steen Bønløkke Pedersen, Niels Jessen, Lars Porskjaer Christensen, Henning Grønbaek. Effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatmentJournal of Gastroenterology and Hepatology 2016; 31(3): 668 doi: 10.1111/jgh.13151
22
Ji‐Won Kim, Ye‐Jee Lee, Young‐Hye You, Min Kyong Moon, Kun‐Ho Yoon, Yu‐Bae Ahn, Seung‐Hyun Ko. Effect of sodium‐glucose cotransporter 2 inhibitor, empagliflozin, and α‐glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetesJournal of Cellular Biochemistry 2019; 120(5): 8534 doi: 10.1002/jcb.28141
23
Anne Korsholm, Thomas Kjær, Marie Ornstrup, Steen Pedersen. Comprehensive Metabolomic Analysis in Blood, Urine, Fat, and Muscle in Men with Metabolic Syndrome: A Randomized, Placebo-Controlled Clinical Trial on the Effects of Resveratrol after Four Months’ TreatmentInternational Journal of Molecular Sciences 2017; 18(3): 554 doi: 10.3390/ijms18030554
24
Jia Liu, Yuan Xu, Yanjin Hu, Guang Wang. The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapyMetabolism 2015; 64(3): 380 doi: 10.1016/j.metabol.2014.11.009
25
Kang Cheng, Zhihua Song, Hao Zhang, Simian Li, Chao Wang, Lili Zhang, Tian Wang. The therapeutic effects of resveratrol on hepatic steatosis in high-fat diet-induced obese mice by improving oxidative stress, inflammation and lipid-related gene transcriptional expressionMedical Molecular Morphology 2019; 52(4): 187 doi: 10.1007/s00795-019-00216-7
26
Jenifer Trepiana, Stéphanie Krisa, Elodie Renouf, María Puy Portillo. Resveratrol Metabolites Are Able to Reduce Steatosis in Cultured HepatocytesPharmaceuticals 2020; 13(10): 285 doi: 10.3390/ph13100285
27
Mitchell R. McGill, Kuo Du, James L. Weemhoff, Hartmut Jaeschke. Critical review of resveratrol in xenobiotic-induced hepatotoxicityFood and Chemical Toxicology 2015; 86: 309 doi: 10.1016/j.fct.2015.11.003
28
Markus M. Heimesaat, Soraya Mousavi, Ulrike Escher, Fábia Daniela Lobo de Sá, Elisa Peh, Jörg-Dieter Schulzke, Sophie Kittler, Roland Bücker, Stefan Bereswill. Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention StudyMicroorganisms 2020; 8(12): 1858 doi: 10.3390/microorganisms8121858
29
Mari Anoushka Ricker, William Christian Haas. Anti-Inflammatory Diet in Clinical Practice: A ReviewNutrition in Clinical Practice 2017; 32(3): 318 doi: 10.1177/0884533617700353
30
Somayyeh Asghari, Mohammad Asghari-Jafarabadi, Mohammad-Hossein Somi, Seyed-Mostafa Ghavami, Maryam Rafraf. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical TrialJournal of the American College of Nutrition 2018; 37(3): 223 doi: 10.1080/07315724.2017.1392264
31
Sara Heebøll, Martin Kreuzfeldt, Stephen Hamilton-Dutoit, Marianne Kjær Poulsen, Hans Stødkilde-Jørgensen, Holger Jon Møller, Niels Jessen, Kasper Thorsen, Ylva Kristina Hellberg, Steen Bønløkke Pedersen, Henning Grønbæk. Placebo-controlled, randomised clinical trial: high-dose resveratrol treatment for non-alcoholic fatty liver diseaseScandinavian Journal of Gastroenterology 2016; 51(4): 456 doi: 10.3109/00365521.2015.1107620
32
Maria-Christina Scherzberg, Andreas Kiehl, Aleksandra Zivkovic, Holger Stark, Jürgen Stein, Robert Fürst, Dieter Steinhilber, Sandra Ulrich-Rückert. Structural modification of resveratrol leads to increased anti-tumor activity, but causes profound changes in the mode of actionToxicology and Applied Pharmacology 2015; 287(1): 67 doi: 10.1016/j.taap.2015.05.020
33
Sharon M. Gwaltney-Brant. Nutraceuticals2016; : 87 doi: 10.1016/B978-0-12-802147-7.00007-3
34
Jelica Grujic-Milanovic, Zoran Miloradovic, Djurdjica Jovovic, Vesna Jacevic, Ivica Milosavljevic, Sladjan D. Milanovic, Nevena Mihailovic-Stanojevic. The red wine polyphenol, resveratrol improves hemodynamics, oxidative defence and aortal structure in essential and malignant hypertensionJournal of Functional Foods 2017; 34: 266 doi: 10.1016/j.jff.2017.04.035
35
Tannaz Eslamparast, Sareh Eghtesad, Hossein Poustchi, Azita Hekmatdoost. Recent advances in dietary supplementation, in treating non-alcoholic fatty liver diseaseWorld Journal of Hepatology 2015; 7(2): 204-212 doi: 10.4254/wjh.v7.i2.204
36
Qing-Rong Pan, Yan-Long Ren, Wen-Xian Liu, Yan-Jin Hu, Jin-Su Zheng, Yuan Xu, Guang Wang. Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in ratsNutrition Research 2015; 35(7): 576 doi: 10.1016/j.nutres.2015.05.006
37
Rehab M. Badi, Dalia G. Mostafa, Eman F. Khaleel, Huda H. Satti. Resveratrol protects against hepatic insulin resistance in a rat's model of non‐alcoholic fatty liver disease by down‐regulation of GPAT ‐1 and DGAT 2 expression and inhibition of PKC membranous translocation Clinical and Experimental Pharmacology and Physiology 2019; 46(6): 545 doi: 10.1111/1440-1681.13074
38
Eman F. Khaleel, Ghada A. Abdel-Aleem, Dalia G. Mostafa. Resveratrol improves high-fat diet induced fatty liver and insulin resistance by concomitantly inhibiting proteolytic cleavage of sterol regulatory element-binding proteins, free fatty acid oxidation, and intestinal triglyceride absorptionCanadian Journal of Physiology and Pharmacology 2018; 96(2): 145 doi: 10.1139/cjpp-2017-0001
39
Hüseyin ÖZDEN, Muhammed GÖMEÇ, Yaşar ŞAHİN, Gökhan KARACA, Huri BULUT, Asuman KİLİTCİ. Protective effect of resveratrol on the kidney in rats under immunosuppression with tacrolimusJournal of Surgery and Medicine 2021; 5(2): 144 doi: 10.28982/josam.831592
40
Sara Heebøll, Karen Louise Thomsen, Andrew Clouston, Elias Immanuel Sundelin, Yulia Radko, Lars Porskjær Christensen, Mehdi Ramezani-Moghadam, Martin Kreutzfeldt, Steen Bønløkke Pedersen, Niels Jessen, Lionel Hebbard, Jacob George, Henning Grønbæk. Effect of resveratrol on experimental non-alcoholic steatohepatitisPharmacological Research 2015; : 34 doi: 10.1016/j.phrs.2015.03.005